| Literature DB >> 32647545 |
Katarzyna Justyna1, Joanna Małolepsza1, Damian Kusy1, Waldemar Maniukiewicz2, Katarzyna M Błażewska1.
Abstract
The McKenna reaction is a well-known and popular method for the efficient and mild synthesis of organophosphorus acids. Bromotrimethylsilane (BTMS) is the main reagent in this reaction, which transforms dialkyl phosphonate esters into bis(trimethylsilyl)esters, which are then easily converted into the target acids. However, the versatile character of the McKenna reaction is not always used to its full extent, due to formation of side products. Herein, demonstrated by using model examples we have not only analyzed the typical side processes accompanying the McKenna reaction, but also uncovered new ones. Further, we discovered that some commonly recommended precautions did not always circumvent the side reactions. The proposed results and recommendations may facilitate the synthesis of phosphonic acids.Entities:
Keywords: McKenna reaction; bromotrimethylsilane; organophosphorus acid; oxazole; phosphonate ester
Year: 2020 PMID: 32647545 PMCID: PMC7323628 DOI: 10.3762/bjoc.16.119
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.883
Scheme 1Schematic overview of the McKenna reaction including the decomposition of BTMS in protic solvents. The desired products of the McKenna reaction are presented in green and the reagents that potentially are responsible for side reactions are presented in red.
Figure 1The model compounds used for this study (in red: the functionality of the molecules vulnerable to side reactions).
Scheme 2Formation of the side products derived from 10. Conditions: An equimolar mixture of propargylamide 10 and triethyl phosphonoacetate (8a) in ACN stirred at 35 °C in the presence of BTMS.
Investigation of the reaction between propargylamide 10 and BTMS.
| entry | BTMSa | TEA | other | time | ratio |
| 1b | + | – | – | 24 | 0.78:0.07:0.07:0.08 |
| 2 | +c | – | Cu | 24 | 0.39:0.23:0.20:0.18 |
| 3 | + | – | CuBr | 48 | 0.68:0.07:0.09:0.07d |
| 4e | – | – | CuBr (0.1) | 48 | 1:0:0:0 |
| 5 | + | – | H2O | 24 | 0:0.63:0.2:0.17 |
| 7 | – | – | 33% HBr in AcOH (1) | 24 | 0.67:0.27:0.03:0.03 |
| 8 | – | – | TFA (1.3) | 24 | 1:0:0:0 |
aBTMS (12 equiv) distilled and stored under Ar in a sealed ampule was used, unless otherwise stated; bthe same result was obtained when the reaction was carried out in a Schlenk apparatus, under strictly anhydrous conditions; ccommercially available reagent stabilized with copper wire was used; dthe dibrominated product derived from 10 was also observed (9%); ethe reaction was carried out in the absence of triethyl phosphonoacetate (8a).
Scheme 3Addition of HBr to compound 11.
Scheme 4N-Alkylation of 9.
Scheme 5N-Alkylation of 12.
Investigation of the reaction between compound 12, phosphonoacetates 8 and BTMS.a
| entry | R1 | R2 | TEA | ratio |
| 1 | Et | 6 | 0.18:0.82 | |
| 2 | Et | 3 | 0.58:0.42 | |
| 3 | Et | – | 1:0 | |
| 4 | Et | iPr | 10 | 1:0 |
aReactions carried out for 24 h at 35 °C in the presence of the appropriate phosphonoacetate (see Scheme 5) using distilled BTMS.
Scheme 6Exchange of the chlorine substituent with bromine in 2-chloro-N-phenethylacetamide (13) under McKenna reaction conditions.
Studies on the reactivity of 13 in the presence of BTMS.a
| entry | solvent | TEA | PCb | time | ratio |
| 1 | ACN | – | + | 1 | 0.15:0.85 |
| 2 | CDCl3 | – | + | 3 | 0.58:0.42 |
| 3 | CDCl3 | – | – | 24 (rt) | 0.5:0.5 |
| 4 | ACN | 1 | + | 3 | 0.57:0.43 |
| 5 | CDCl3 | 1 | + | 3 | 0.64:0.36 |
| 6 | ACN | – | – | 24 | 0:1 |
aThe reaction was carried out with distilled BTMS (6 equiv) at 35 °C, except for entry 3, where the reaction was carried out at rt; bPC: trialkyl phosphonocarboxylate 8a.
The stability of compounds 8/9 during the McKenna reaction.a,b.
| compound | silylation | solvolysisc | |||||
| entry | R | R1 | amine | time | ester bond cleavage | BTMS | molar ratio |
| 1 | H | Et | – | 24 | 0 | – | 0.98:0.02:0 (24 h) |
| 2 | H | Et | – | 24 | 0 | + | 0.63:0.07:0.30 (18 h)d |
| 3 | H | – | 1 | 30% | – | 0:1:0 (1 h) | |
| 4 | H | TEA (1) | 1 | 0 | – | – | |
| 5 | H | pyridine (1 or 2) | 24 | 47% | – | 0.5:0.5:0 | |
| 7 | 3-Py-CH2- | – | 24 | 0 | – | 1:0:0 (24 h) | |
| 8 | 3-Py-CH2- | – | 24 | 0 | + | 0:1:0 | |
aReaction carried out in CD3CN at rt with 12 equiv BTMS (distilled), unless defined otherwise; bfor analogs R = H, the McKenna reaction completed within 1 h; for analogs R = pyridin-3-ylmethyl, the McKenna reaction was completed within 2 h; cthe experiment was run on the same sample as the one used for the BTMS studies. For this, the sample was evaporated and directly subjected to solvolysis with MeOD/D2O 20:1 (v/v) for 5–10 minutes, unless stated otherwise in parentheses; dsolvolysis: MeOH/H2O 40:1, BTMS (0.5 equiv); ethe same result was obtained after 24 h.